MicroRNA profiling identifies a novel compound with antidepressant properties.

Patients with traumatic brain injury (TBI) are frequently diagnosed with depression. Together, these two leading causes of death and disability significantly contribute to the global burden of healthcare costs. However, there are no drug treatments for TBI and antidepressants are considered off-labe...

詳細記述

書誌詳細

出版年:	PLoS ONE
主要な著者:	Stacy L Sell, Deborah R Boone, Harris A Weisz, Cesar Cardenas, Hannah E Willey, Ian J Bolding, Maria-Adelaide Micci, Michael T Falduto, Karen E O Torres, Douglas S DeWitt, Donald S Prough, Helen L Hellmich
フォーマット:	論文
言語:	英語
出版事項:	Public Library of Science (PLoS) 2019-01-01
オンライン･アクセス:	https://doi.org/10.1371/journal.pone.0221163